Cargando…
Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling
The ATPase family, AAA domain containing 2 (ATAD2) is highly expressed in multiple cancers. We aim to understand the clinical and biological significance of ATAD2 over-expression in hepatocellular carcinoma (HCC), as a means to validate it as a therapeutic target in HCC. We demonstrated that ATAD2 w...
Autores principales: | Lu, Wen-Jing, Chua, Mei-Sze, So, Samuel K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747184/ https://www.ncbi.nlm.nih.gov/pubmed/26497681 |
Ejemplares similares
-
FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway
por: Ma, Dong, et al.
Publicado: (2023) -
TES inhibits colorectal cancer progression through activation of p38
por: Li, Huili, et al.
Publicado: (2016) -
Role of p53 suppression in the pathogenesis of hepatocellular carcinoma
por: Choudhary, Heena B, et al.
Publicado: (2023) -
LZAP Inhibits p38 MAPK (p38) Phosphorylation and Activity by Facilitating p38 Association with the Wild-Type p53 Induced Phosphatase 1 (WIP1)
por: An, Hanbing, et al.
Publicado: (2011) -
Pressure suppresses hepatocellular glycogen synthesis through activating the p53/Pten pathway
por: Shen, Junwei, et al.
Publicado: (2019)